Wuhan Neurophth Biotechnology Limited Company

This study tests a gene therapy called NR082 for Leber's hereditary optic neuropathy (LHON), a rare inherited eye disease that leads to vision loss. About 95 people aged 12 to 75 with a specific gene mutation (ND4) and vision problems lasting 6 months to 10 years will receive a s…